The document outlines the key stages of the drug discovery process, including identifying genetic and cellular targets, synthesizing and isolating compounds through combinatorial chemistry and high-throughput screening, developing structure-activity relationships through in silico and in vitro studies, evaluating drug affinity and selectivity in cellular and disease models, testing lead candidates in animal models of disease states, and conducting clinical trials and therapeutics in humans.
Drug discovery process style 5 powerpoint presentation slides db ppt templatesSlideTeam.net
The document outlines the key stages in the drug discovery process, including target selection, lead discovery, drug development, preclinical testing, and clinical trials. Genetic and cellular targets are identified through genomics and proteomics. Combinatorial chemistry and high-throughput screening are used to develop compound libraries and identify potential drug candidates. Lead compounds are refined through medicinal chemistry and testing in cellular and animal disease models. Top candidates then progress to clinical trials in humans to test for safety and efficacy.
Traditional drug discovery process design 6 powerpoint ppt slides.SlideTeam.net
The document describes two approaches to drug discovery: the traditional approach and the SWITCH drug re-profiling approach. The traditional approach involves lengthy timelines of 0.5-6 years across target identification, validation, lead identification, candidate optimization, pre-clinical trials, and clinical trials. The SWITCH approach aims to shorten timelines by mining existing drug data to identify new therapeutic uses for existing drugs and performing a clinical proof of concept trial within 0.5-1 year on a re-profiled drug.
Drug discovery process style 6 powerpoint presentation templatesSlideTeam.net
The document describes two approaches to drug discovery: traditional drug discovery and a SWITCH drug re-profiling approach. The traditional approach involves multiple sequential steps over 6-10 years, including target identification, validation, lead identification, candidate optimization, pre-clinical testing, and clinical trials. The SWITCH approach uses data mining to identify existing drugs that could be re-purposed for new indications, potentially shortening the process to just 0.5-1 years for target identification and proof-of-concept clinical trials on re-profiled drugs.
Target selection lead discovery medicinal drug discovery strategy design 5 po...SlideTeam.net
The document describes the multi-stage drug discovery process, including cellular and genetic target identification, compound synthesis and isolation, library development, drug affinity and selectivity testing, use of disease models in animals and cells, and clinical trials in humans. Key stages involve genomic and proteomic analysis to select drug targets, combinatorial chemistry and high-throughput screening to develop compound libraries, and refinement of lead candidates through medicinal chemistry, in vitro and in vivo studies.
Target selection lead discovery medicinal drug discovery process style design...SlideTeam.net
The document outlines the multi-step drug discovery process, including cellular and genetic target identification, compound synthesis and isolation, library development, drug affinity and selectivity testing, animal disease modeling, and clinical trials. Key steps involve genomics, proteomics, high-throughput screening, medicinal chemistry, in vitro and in vivo studies to identify lead candidates and refine drug properties before progressing to clinical testing.
Target selection lead discovery medicinal drug discovery process design 5 pow...SlideTeam.net
The document outlines the key stages of the drug discovery process, including identifying genetic and cellular targets, synthesizing and isolating compounds through combinatorial chemistry and high-throughput screening, developing structure-activity relationships through in silico and in vitro studies, evaluating drug affinity and selectivity in cellular and disease models, testing lead candidates in animal models of disease states, and conducting clinical trials and therapeutics in humans.
Target selection lead discovery medicinal drug discovery process style design...SlideTeam.net
The document outlines the multi-step drug discovery process, including cellular and genetic target identification, compound synthesis and isolation, library development, drug affinity and selectivity testing, animal disease modeling, and clinical trials. Key steps involve genomics, proteomics, high-throughput screening, medicinal chemistry, in vitro and in vivo studies to identify lead candidates and refine drug properties before progressing to clinical testing.
Target selection lead discovery medicinal drug discovery strategy style desig...SlideTeam.net
The document outlines the key stages of the drug discovery process, including identifying genetic and cellular targets, synthesizing and isolating compounds through combinatorial chemistry and high-throughput screening, developing structure-activity relationships through in silico and in vitro studies, evaluating drug affinity and selectivity in cellular and disease models, testing lead candidates in animal models of disease states, and conducting clinical trials and therapeutics in humans.
Drug discovery process style 5 powerpoint presentation slides db ppt templatesSlideTeam.net
The document outlines the key stages in the drug discovery process, including target selection, lead discovery, drug development, preclinical testing, and clinical trials. Genetic and cellular targets are identified through genomics and proteomics. Combinatorial chemistry and high-throughput screening are used to develop compound libraries and identify potential drug candidates. Lead compounds are refined through medicinal chemistry and testing in cellular and animal disease models. Top candidates then progress to clinical trials in humans to test for safety and efficacy.
Traditional drug discovery process design 6 powerpoint ppt slides.SlideTeam.net
The document describes two approaches to drug discovery: the traditional approach and the SWITCH drug re-profiling approach. The traditional approach involves lengthy timelines of 0.5-6 years across target identification, validation, lead identification, candidate optimization, pre-clinical trials, and clinical trials. The SWITCH approach aims to shorten timelines by mining existing drug data to identify new therapeutic uses for existing drugs and performing a clinical proof of concept trial within 0.5-1 year on a re-profiled drug.
Drug discovery process style 6 powerpoint presentation templatesSlideTeam.net
The document describes two approaches to drug discovery: traditional drug discovery and a SWITCH drug re-profiling approach. The traditional approach involves multiple sequential steps over 6-10 years, including target identification, validation, lead identification, candidate optimization, pre-clinical testing, and clinical trials. The SWITCH approach uses data mining to identify existing drugs that could be re-purposed for new indications, potentially shortening the process to just 0.5-1 years for target identification and proof-of-concept clinical trials on re-profiled drugs.
Target selection lead discovery medicinal drug discovery strategy design 5 po...SlideTeam.net
The document describes the multi-stage drug discovery process, including cellular and genetic target identification, compound synthesis and isolation, library development, drug affinity and selectivity testing, use of disease models in animals and cells, and clinical trials in humans. Key stages involve genomic and proteomic analysis to select drug targets, combinatorial chemistry and high-throughput screening to develop compound libraries, and refinement of lead candidates through medicinal chemistry, in vitro and in vivo studies.
Target selection lead discovery medicinal drug discovery process style design...SlideTeam.net
The document outlines the multi-step drug discovery process, including cellular and genetic target identification, compound synthesis and isolation, library development, drug affinity and selectivity testing, animal disease modeling, and clinical trials. Key steps involve genomics, proteomics, high-throughput screening, medicinal chemistry, in vitro and in vivo studies to identify lead candidates and refine drug properties before progressing to clinical testing.
Target selection lead discovery medicinal drug discovery process design 5 pow...SlideTeam.net
The document outlines the key stages of the drug discovery process, including identifying genetic and cellular targets, synthesizing and isolating compounds through combinatorial chemistry and high-throughput screening, developing structure-activity relationships through in silico and in vitro studies, evaluating drug affinity and selectivity in cellular and disease models, testing lead candidates in animal models of disease states, and conducting clinical trials and therapeutics in humans.
Target selection lead discovery medicinal drug discovery process style design...SlideTeam.net
The document outlines the multi-step drug discovery process, including cellular and genetic target identification, compound synthesis and isolation, library development, drug affinity and selectivity testing, animal disease modeling, and clinical trials. Key steps involve genomics, proteomics, high-throughput screening, medicinal chemistry, in vitro and in vivo studies to identify lead candidates and refine drug properties before progressing to clinical testing.
Target selection lead discovery medicinal drug discovery strategy style desig...SlideTeam.net
The document outlines the key stages of the drug discovery process, including identifying genetic and cellular targets, synthesizing and isolating compounds through combinatorial chemistry and high-throughput screening, developing structure-activity relationships through in silico and in vitro studies, evaluating drug affinity and selectivity in cellular and disease models, testing lead candidates in animal models of disease states, and conducting clinical trials and therapeutics in humans.
Target selection lead discovery medicinal drug discovery strategy style desig...SlideTeam.net
The document presents an overview of the drug discovery process. It involves several stages including identifying cellular and genetic targets through genomics and proteomics, synthesizing and isolating compounds through combinatorial chemistry, developing screening libraries and conducting structure activity studies, determining drug affinity and selectivity through cellular assays and computer modeling, testing candidate drugs in animal models of disease and studying mechanisms of action and behavior, conducting in vitro and in vivo studies, and performing clinical trials and therapeutics in humans. The flowchart outlines the iterative process moving from early research to preclinical and clinical testing.
Target selection lead discovery medicinal drug discovery strategy design 5 po...SlideTeam.net
The document outlines the multi-step drug discovery process, including cellular and genetic target identification, compound synthesis and isolation, library development, drug affinity and selectivity testing, animal disease modeling, and clinical trials. Key steps involve genomics, proteomics, high-throughput screening, medicinal chemistry, in vitro and in vivo studies to identify lead candidates and refine drug properties before progressing to clinical testing.
Target selection lead discovery medicinal drug discovery strategy design 5 po...SlideTeam.net
The document outlines the key stages of the drug discovery process, including identifying genetic and cellular targets, synthesizing and isolating compounds through combinatorial chemistry and high-throughput screening, developing structure-activity relationships through in silico and in vitro studies, evaluating drug affinity and selectivity in cellular and disease models, testing lead candidates in animal models of disease states, and conducting clinical trials and therapeutics in humans.
Target selection lead discovery medicinal drug discovery strategy design 5 po...SlideTeam.net
The document outlines the multi-step drug discovery process, including cellular and genetic target identification, compound synthesis and isolation, library development, drug affinity and selectivity testing, animal disease modeling, and clinical trials. Key steps involve genomics, proteomics, high-throughput screening, medicinal chemistry, in vitro and in vivo studies to identify lead candidates and refine drug properties before progressing to clinical testing.
Target selection lead discovery medicinal drug discovery strategy style desig...SlideTeam.net
The document outlines the multi-step drug discovery process, including cellular and genetic target identification, compound synthesis and isolation, library development, drug affinity and selectivity testing, animal disease modeling, and clinical trials. Key steps involve genomics, proteomics, high-throughput screening, medicinal chemistry, in vitro and in vivo studies to identify lead candidates and refine drug properties before progressing to clinical testing.
Target selection lead discovery medicinal drug discovery process style design...SlideTeam.net
The document outlines the multi-step drug discovery process, including identifying genetic and cellular targets, synthesizing compounds through combinatorial chemistry and high-throughput screening, developing structure-activity relationships through in silico and in vitro studies, evaluating drug affinity and selectivity in cellular disease models, testing lead candidates in animal models of disease states, and conducting clinical trials and therapeutics in humans.
Target selection lead discovery medicinal drug discovery process style design...SlideTeam.net
The document outlines the multi-step drug discovery process, including cellular and genetic target identification, compound synthesis and isolation, library development, drug affinity and selectivity testing, animal disease modeling, and clinical trials. Key steps involve genomics, proteomics, high-throughput screening, medicinal chemistry, in vitro and in vivo studies to identify lead candidates and refine drug properties before progressing to clinical testing.
Target selection lead discovery medicinal drug discovery strategy style desig...SlideTeam.net
The document outlines the key stages of the drug discovery process, including identifying genetic and cellular targets, synthesizing and isolating compounds through combinatorial chemistry and high-throughput screening, developing structure-activity relationships through in silico and in vitro studies, evaluating drug affinity and selectivity in cellular and disease models, testing lead candidates in animal models of disease states, and conducting clinical trials and therapeutics in humans.
Target selection lead discovery medicinal drug discovery process design 5 pow...SlideTeam.net
The document outlines the multi-step drug discovery process, including cellular and genetic target identification, compound synthesis and isolation, library development, drug affinity and selectivity testing, animal disease modeling, and clinical trials. Key steps involve genomics, proteomics, high-throughput screening, medicinal chemistry, in vitro and in vivo studies to identify lead candidates and refine drug properties before progressing to clinical testing.
Drug discovery process style 5 powerpoint presentation templatesSlideTeam.net
The document describes the key stages in the drug discovery process, including cellular and genetic target identification, compound synthesis and isolation, high-throughput screening, lead optimization, preclinical testing in animal models and in vitro/in vivo studies, and clinical trials in humans. The flow diagram shows the iterative process moving from early research to identify biological targets through compound development and testing, culminating in clinical evaluation and potential approval of new therapeutics.
Drug discovery process style 3 powerpoint presentation templatesSlideTeam.net
The document summarizes the key steps in the drug discovery process. It involves:
1) Identifying a biological target molecule through genomic research and functional analysis of genes.
2) Discovering seed lead compounds through high-throughput screening and combinatorial chemistry.
3) Scrutinizing drug candidates through estimation of efficacy, safety evaluation, pharmacokinetics studies, and manufacturing development.
4) Conducting clinical studies and applying for a new drug approval.
Part of the MaRS Best Practices Series - Pre-Clinical development workshop
http://www.marsdd.com/bestpractices
Speaker: Jack Jiang, VP Medicinal and Analytical Chemistry, Ricerca BioSciences
This lecture outlines the different strategies for finding a fragment hit and the subsequent elaboration strategies used in order to increase potency to develop a lead compound in drug discovery.
Drug discovery process powerpoint presentation slides ppt templatesSlideTeam.net
The document describes the drug discovery process. It involves 10,000 to 20,000 candidate drugs undergoing discovery and screening. Promising candidates then undergo lead optimization using combinatorial chemistry and structure-based drug design. Finally, drugs must pass ADMET studies and clinical trials to receive FDA approval and reach the market.
The document discusses the drug discovery process and crisis. It outlines how drugs work by binding to proteins, and how new drugs were traditionally discovered from plant extracts or serendipitously, but are now discovered through large-scale compound screening and rational design based on target structures. The development of a new drug can take decades and billions of dollars. While concerns exist that we may be running out of drugs, continued basic research into human biology, new drug design technologies, and gene therapy methods offer promise for developing new medicines to address this crisis.
Drug Discovery Today: Fighting TB with Technologyrendevilla
This document discusses desktop drug discovery and development using computational methods. It covers rational drug design approaches like computer-aided drug design (CADD), targeting identification and validation, lead discovery and optimization, and preclinical testing using molecular modeling and simulation. Specific examples are provided of structure-based drug design against targets for tuberculosis and the preclinical evaluation of candidate compounds.
This document discusses methods for drug discovery including extracting compounds from natural sources and rational drug design. It describes accidental discoveries like LSD and penicillin. Rational drug design uses structure-based and ligand-based approaches including determining biological targets, virtual screening, molecular docking, and optimization. High-throughput screening tests small molecules and virtual high-throughput screening uses computational methods. Chirality and absolute configuration can be determined through techniques like x-ray crystallography and vibrational circular dichroism. Future directions include continued computational and high-throughput approaches.
WE THE STUDENT OF PHARMACEUTICAL CHEMISTRY FROM GURUNANAK COLLEGE OF PHARMACY HAS PRESENTED QSRR, TO MAKE READERS EASILY AVAILABLE, A COMPLETE TOPIC OF MPHARM 1ST YEAR WHICH WILL MAKE THEIR STUDY AND TO COLLECT DATA MORE EASILY AT A PLACE.
Genetic discoveries can identify drug targets by finding loss-of-function mutations that mimic the desired effect of a drug. These "drug surrogate mutations" provide strong evidence of a target's validity. Two examples are given: 1) A mutation causing sclerosteosis identified SOST as a target for osteoporosis drugs. Antibodies blocking SOST are now in clinical trials. 2) Loss-of-function mutations in IL23 were linked to reduced Crohn's disease risk, identifying IL23 as a drug target before genetic mapping was available, and IL23 antagonists are now in clinical trials. Genetically identifying targets through drug surrogate mutations can significantly improve drug development success rates and lower costs.
Discovery on Target 2014 - The Industry's Preeminent Event on Novel Drug TargetsJaime Hodges
Cambridge Healthtech Institute's 12th Annual Discovery on Target will showcase current and emerging “hot” targets for the pharmaceutical industry, October 8 – 10, 2014 in Boston, MA. Spanning three days, the meeting will bring together more than 900 global attendees, including scientists/technologists, executives, directors, and managers from biopharma, academic, and healthcare organizations. In 2014 the event is comprised of 14 conference tracks which include Epigenetic Readers, Ubiquitin Proteasome, Big Data Discovery, GPCR Drug Discovery, RNAi-Screens-Functional-Genomics, PPI Targets, Protein-Targets, Histone-Methyltransferases-Demethylases, Drug Transporters, Maximizing Efficiency, GPCR Therapeutics, Genomics Screening, Cancer Metabolism and Membrane Production. The 2014 event will offer 200+ scientific presentations across 14 conference tracks, 1 Symposium and 15 conference short courses, 40+ interactive breakout discussion groups, an exhibit hall of 40+ companies, and dedicated poster viewing and networking sessions.
Process flow with round boxes powerpoint ppt slides.SlideTeam.net
The document is a template for creating process flow diagrams using round boxes. It contains instructions for customizing the template by adding text to the boxes and includes examples of process flows laid out with round boxes connected by arrows. The template can be downloaded and text, colors, icons and other elements can be modified to create customized process flow diagrams for presentations.
Target selection lead discovery medicinal drug discovery strategy style desig...SlideTeam.net
The document presents an overview of the drug discovery process. It involves several stages including identifying cellular and genetic targets through genomics and proteomics, synthesizing and isolating compounds through combinatorial chemistry, developing screening libraries and conducting structure activity studies, determining drug affinity and selectivity through cellular assays and computer modeling, testing candidate drugs in animal models of disease and studying mechanisms of action and behavior, conducting in vitro and in vivo studies, and performing clinical trials and therapeutics in humans. The flowchart outlines the iterative process moving from early research to preclinical and clinical testing.
Target selection lead discovery medicinal drug discovery strategy design 5 po...SlideTeam.net
The document outlines the multi-step drug discovery process, including cellular and genetic target identification, compound synthesis and isolation, library development, drug affinity and selectivity testing, animal disease modeling, and clinical trials. Key steps involve genomics, proteomics, high-throughput screening, medicinal chemistry, in vitro and in vivo studies to identify lead candidates and refine drug properties before progressing to clinical testing.
Target selection lead discovery medicinal drug discovery strategy design 5 po...SlideTeam.net
The document outlines the key stages of the drug discovery process, including identifying genetic and cellular targets, synthesizing and isolating compounds through combinatorial chemistry and high-throughput screening, developing structure-activity relationships through in silico and in vitro studies, evaluating drug affinity and selectivity in cellular and disease models, testing lead candidates in animal models of disease states, and conducting clinical trials and therapeutics in humans.
Target selection lead discovery medicinal drug discovery strategy design 5 po...SlideTeam.net
The document outlines the multi-step drug discovery process, including cellular and genetic target identification, compound synthesis and isolation, library development, drug affinity and selectivity testing, animal disease modeling, and clinical trials. Key steps involve genomics, proteomics, high-throughput screening, medicinal chemistry, in vitro and in vivo studies to identify lead candidates and refine drug properties before progressing to clinical testing.
Target selection lead discovery medicinal drug discovery strategy style desig...SlideTeam.net
The document outlines the multi-step drug discovery process, including cellular and genetic target identification, compound synthesis and isolation, library development, drug affinity and selectivity testing, animal disease modeling, and clinical trials. Key steps involve genomics, proteomics, high-throughput screening, medicinal chemistry, in vitro and in vivo studies to identify lead candidates and refine drug properties before progressing to clinical testing.
Target selection lead discovery medicinal drug discovery process style design...SlideTeam.net
The document outlines the multi-step drug discovery process, including identifying genetic and cellular targets, synthesizing compounds through combinatorial chemistry and high-throughput screening, developing structure-activity relationships through in silico and in vitro studies, evaluating drug affinity and selectivity in cellular disease models, testing lead candidates in animal models of disease states, and conducting clinical trials and therapeutics in humans.
Target selection lead discovery medicinal drug discovery process style design...SlideTeam.net
The document outlines the multi-step drug discovery process, including cellular and genetic target identification, compound synthesis and isolation, library development, drug affinity and selectivity testing, animal disease modeling, and clinical trials. Key steps involve genomics, proteomics, high-throughput screening, medicinal chemistry, in vitro and in vivo studies to identify lead candidates and refine drug properties before progressing to clinical testing.
Target selection lead discovery medicinal drug discovery strategy style desig...SlideTeam.net
The document outlines the key stages of the drug discovery process, including identifying genetic and cellular targets, synthesizing and isolating compounds through combinatorial chemistry and high-throughput screening, developing structure-activity relationships through in silico and in vitro studies, evaluating drug affinity and selectivity in cellular and disease models, testing lead candidates in animal models of disease states, and conducting clinical trials and therapeutics in humans.
Target selection lead discovery medicinal drug discovery process design 5 pow...SlideTeam.net
The document outlines the multi-step drug discovery process, including cellular and genetic target identification, compound synthesis and isolation, library development, drug affinity and selectivity testing, animal disease modeling, and clinical trials. Key steps involve genomics, proteomics, high-throughput screening, medicinal chemistry, in vitro and in vivo studies to identify lead candidates and refine drug properties before progressing to clinical testing.
Drug discovery process style 5 powerpoint presentation templatesSlideTeam.net
The document describes the key stages in the drug discovery process, including cellular and genetic target identification, compound synthesis and isolation, high-throughput screening, lead optimization, preclinical testing in animal models and in vitro/in vivo studies, and clinical trials in humans. The flow diagram shows the iterative process moving from early research to identify biological targets through compound development and testing, culminating in clinical evaluation and potential approval of new therapeutics.
Drug discovery process style 3 powerpoint presentation templatesSlideTeam.net
The document summarizes the key steps in the drug discovery process. It involves:
1) Identifying a biological target molecule through genomic research and functional analysis of genes.
2) Discovering seed lead compounds through high-throughput screening and combinatorial chemistry.
3) Scrutinizing drug candidates through estimation of efficacy, safety evaluation, pharmacokinetics studies, and manufacturing development.
4) Conducting clinical studies and applying for a new drug approval.
Part of the MaRS Best Practices Series - Pre-Clinical development workshop
http://www.marsdd.com/bestpractices
Speaker: Jack Jiang, VP Medicinal and Analytical Chemistry, Ricerca BioSciences
This lecture outlines the different strategies for finding a fragment hit and the subsequent elaboration strategies used in order to increase potency to develop a lead compound in drug discovery.
Drug discovery process powerpoint presentation slides ppt templatesSlideTeam.net
The document describes the drug discovery process. It involves 10,000 to 20,000 candidate drugs undergoing discovery and screening. Promising candidates then undergo lead optimization using combinatorial chemistry and structure-based drug design. Finally, drugs must pass ADMET studies and clinical trials to receive FDA approval and reach the market.
The document discusses the drug discovery process and crisis. It outlines how drugs work by binding to proteins, and how new drugs were traditionally discovered from plant extracts or serendipitously, but are now discovered through large-scale compound screening and rational design based on target structures. The development of a new drug can take decades and billions of dollars. While concerns exist that we may be running out of drugs, continued basic research into human biology, new drug design technologies, and gene therapy methods offer promise for developing new medicines to address this crisis.
Drug Discovery Today: Fighting TB with Technologyrendevilla
This document discusses desktop drug discovery and development using computational methods. It covers rational drug design approaches like computer-aided drug design (CADD), targeting identification and validation, lead discovery and optimization, and preclinical testing using molecular modeling and simulation. Specific examples are provided of structure-based drug design against targets for tuberculosis and the preclinical evaluation of candidate compounds.
This document discusses methods for drug discovery including extracting compounds from natural sources and rational drug design. It describes accidental discoveries like LSD and penicillin. Rational drug design uses structure-based and ligand-based approaches including determining biological targets, virtual screening, molecular docking, and optimization. High-throughput screening tests small molecules and virtual high-throughput screening uses computational methods. Chirality and absolute configuration can be determined through techniques like x-ray crystallography and vibrational circular dichroism. Future directions include continued computational and high-throughput approaches.
WE THE STUDENT OF PHARMACEUTICAL CHEMISTRY FROM GURUNANAK COLLEGE OF PHARMACY HAS PRESENTED QSRR, TO MAKE READERS EASILY AVAILABLE, A COMPLETE TOPIC OF MPHARM 1ST YEAR WHICH WILL MAKE THEIR STUDY AND TO COLLECT DATA MORE EASILY AT A PLACE.
Genetic discoveries can identify drug targets by finding loss-of-function mutations that mimic the desired effect of a drug. These "drug surrogate mutations" provide strong evidence of a target's validity. Two examples are given: 1) A mutation causing sclerosteosis identified SOST as a target for osteoporosis drugs. Antibodies blocking SOST are now in clinical trials. 2) Loss-of-function mutations in IL23 were linked to reduced Crohn's disease risk, identifying IL23 as a drug target before genetic mapping was available, and IL23 antagonists are now in clinical trials. Genetically identifying targets through drug surrogate mutations can significantly improve drug development success rates and lower costs.
Discovery on Target 2014 - The Industry's Preeminent Event on Novel Drug TargetsJaime Hodges
Cambridge Healthtech Institute's 12th Annual Discovery on Target will showcase current and emerging “hot” targets for the pharmaceutical industry, October 8 – 10, 2014 in Boston, MA. Spanning three days, the meeting will bring together more than 900 global attendees, including scientists/technologists, executives, directors, and managers from biopharma, academic, and healthcare organizations. In 2014 the event is comprised of 14 conference tracks which include Epigenetic Readers, Ubiquitin Proteasome, Big Data Discovery, GPCR Drug Discovery, RNAi-Screens-Functional-Genomics, PPI Targets, Protein-Targets, Histone-Methyltransferases-Demethylases, Drug Transporters, Maximizing Efficiency, GPCR Therapeutics, Genomics Screening, Cancer Metabolism and Membrane Production. The 2014 event will offer 200+ scientific presentations across 14 conference tracks, 1 Symposium and 15 conference short courses, 40+ interactive breakout discussion groups, an exhibit hall of 40+ companies, and dedicated poster viewing and networking sessions.
Process flow with round boxes powerpoint ppt slides.SlideTeam.net
The document is a template for creating process flow diagrams using round boxes. It contains instructions for customizing the template by adding text to the boxes and includes examples of process flows laid out with round boxes connected by arrows. The template can be downloaded and text, colors, icons and other elements can be modified to create customized process flow diagrams for presentations.
This document describes an online wellness program that provides tools and strategies to improve health, energy, and lifestyle choices. The program consists of modules that help participants assess their current wellness, identify health goals, learn about nutrition, exercise, supplements, and other wellness topics. Upon completion, participants will have gained a sense of life purpose and vision along with tools to design a healthy lifestyle. Previous participants provided positive testimonials, praising the program for being informative, comprehensive, and helping them make impactful changes.
Animal models are important tools in toxicological and biomedical research. Regulations aim to ensure animal welfare while enabling scientific progress. Key points of regulations include:
- Licensing of research facilities and oversight by ethics committees.
- Focus on replacing, reducing and refining animal use (3Rs principle).
- Standards for humane care and treatment of research animals.
- Requirements vary by country but most have adopted versions of the 3Rs and facility licensing with inspections. Self-regulation is common but some places have more direct legal oversight.
This document discusses ethnopharmacology, which is the scientific study of materials used as medicines by different cultural groups. It notes that ethnopharmacology is a branch of ethnobotany and involves multiple disciplines. The document outlines the historical development of ethnopharmacology and the process of drug discovery using its approach. This includes obtaining information from sources, scientific investigation through extraction, activity testing, and chemical examination. It also discusses some problems and questions regarding ethnopharmacology, such as reliability of information and intellectual property issues.
The document provides 3 examples of flow charts: 1) A program that adds two numbers with steps of input, calculation, and display. 2) A program that checks if student marks are above 40 to display "Pass" or "Fail" with steps of input, condition check, and output. 3) A program that calculates the sum of the first 50 natural numbers in a loop with initialization, incrementation, summation, and output steps.
High-throughput screening is a process used in drug discovery to rapidly test large numbers of chemical compounds and substances against a biological target. It allows researchers to quickly screen millions of potential candidate compounds. The goal is to identify initial "hits" or active compounds that can then be further optimized into potential drug "leads". Key aspects of high-throughput screening include using miniaturized assay plates with many wells, robotics for liquid handling, sensitive detectors to read assay results, and data processing software to analyze large datasets from multiple tests. This allows researchers to potentially screen over 100,000 compounds per day in their search for new medicines.
Back Rapid lead compounds discovery through high-throughput screeningrita martin
High-throughput screening process are used by today most of the drug discovery industries, this process helps pharmaceutical researches to make drug discovery process faster and also increase the quality and quantity of drugs production. This process in combination with robotics, data processing and control software, liquid handling devices and sensitive detectors allows a researcher to quickly conduct millions of chemical, genetic or pharmacological tests
High throughput screening (HTS) at iNovaciaiNovacia AB
iNovacia offers high quality high-throughput screening services supported by a compound collection and screening libraries of highest international standards. iNovacia has a broad experience with all major target families and assay types.
The high throughput screening is the first step of the docking or computational method of drug discovery. This slide will help you to understand the basic things in HTVS.
This document discusses process validation and summarizes the key changes between the 1987 FDA guidance and the 2011 revised guidance. It outlines a three stage process validation approach: Stage 1 involves process design and understanding; Stage 2 is process qualification where batches are produced to demonstrate the process is capable of consistent commercial manufacturing; and Stage 3 is continued process verification to ensure the process remains in control during routine production. The revised guidance emphasizes a more holistic and risk-based approach across the product lifecycle compared to the previous terminal approach focused on a set number of validation batches.
Teriparatide (Forteo) is an effective treatment for osteoporosis that works by stimulating new bone formation. It increases bone mineral density, improves bone microarchitecture, and reduces the risk of fractures. While other medications inhibit bone resorption, teriparatide has an anabolic effect through its similar structure to parathyroid hormone.
This document discusses the field of ethnopharmacology, which is the scientific study of medicinal substances used by different cultural groups. It provides examples of many plants and the indigenous medicinal uses of those plants, including yew, coca, willow, opium poppy, and ginseng. It also describes how some modern pharmaceuticals were developed from studying ethnopharmacological substances, such as aspirin from willow bark, quinine from cinchona, and taxol from yew trees.
High Throughput Screening (HTS) is a drug discovery process that uses automation to quickly assay a large number of compounds against biological or biochemical targets to identify potential drug candidates. Key aspects of HTS include testing compounds in microtiter plates with 96, 384, or 1536 wells using assays like cell-based, enzyme, or tissue response tests. HTS allows for high speed, sensitivity, and reproducibility in screening large libraries of compounds cost effectively. Detection methods used in HTS include spectroscopy, chromatography, calorimetry, and microscopy.
Combinatorial chemistry allows for the parallel synthesis and screening of large libraries of compounds. It involves combining sets of building blocks to generate many new molecules simultaneously. Techniques include solid and solution phase synthesis. Solid phase uses a solid support while solution phase lacks purification steps. Detection methods identify hits rapidly using hyphenated analytical techniques. Combinatorial chemistry has been applied to develop new drugs and agrochemicals by exploring vast areas of chemical space.
Chronopharmacology is the study of variations in drug effects over biological times and circadian rhythms. It considers how drugs interact with living systems depending on the time of day they are administered. Biological rhythms like circadian (24-hour), ultradian (<20 hours), and infradian (>28 hours) rhythms influence physiological functions and drug pharmacokinetics and pharmacodynamics. Chronotherapy aims to increase drug efficacy and safety by timing drug administration according to biological rhythms. It has applications in treating cancers, asthma, hypertension, strokes, and other conditions. Recent advances include circadian-aligned drug delivery systems and future approaches may integrate chronopharmacology with systems biology and nanomedicine.
How to make create genomic research target molecules drug discovery strategy ...SlideTeam.net
The document outlines the key steps in the drug discovery process:
1. Identification of target molecules through genomic research and functional analysis of genes and enzymes.
2. Discovery of seed lead compounds through high-throughput screening and combinatorial chemistry.
3. Scrutiny of drug candidates including estimation of drug efficacy and safety evaluation.
4. Manufacturing development and clinical studies prior to new drug application and launch.
How to make create genomic research target molecules drug discovery strategy ...SlideTeam.net
The drug discovery process involves several steps:
1) Identification of a biological target like receptors or enzymes.
2) Discovery of seed compounds that can bind to the target through high-throughput screening.
3) Scrutiny of potential drug candidates where their efficacy and safety are estimated.
Biotechnology Industry has changed a lot during last decade , which means moving ahead from traditional ways to more advanced technological developments
2012 Biotechnology Industry is not the same as it was in 2001
Metabolomics is the newest hype in the 'omics' family. Although defined as highly important to recent biological research, the analytical science applied is far from acceptable for the majority of publications that appear nowadays. Take a look at our approach to tackle the metabolomics issue, which remains a new name for an old science.
This document discusses systems pharmacology and applying a systems-based approach to understanding drug action and effects. It begins by outlining some big questions in pharmacology research, such as predicting drug efficacy and toxicity. It then discusses concepts like polypharmacology, where one drug can have multiple targets, and how drug binding is a dynamic process. The document proposes using multiscale modeling to simulate these complex biological processes. It describes developing computational methods to explore the large conformational and functional spaces involved. Several applications of these approaches are mentioned, such as drug repositioning and designing personalized medicines. Overall, the document advocates applying systems-level modeling and simulations to better understand how drugs work in the body.
Representing Microarray Experiment Metadata Using Provenance ModelsJim McCusker
This document discusses representing experimental metadata as provenance using provenance models. It argues that experimental metadata is a type of provenance and evaluates mapping microarray metadata onto the Open Provenance Model and Proof Markup Language. It describes converting microarray data from MAGE-TAB format to RDF and then applying rules to generate equivalent provenance representations. Both OPM and PML are found to adequately represent the data, though some attributes are missing from each. Future work could integrate this provenance data with other systems and evaluate coverage on additional use cases.
Biovays is a biomarker solutions provider that offers specialized services to support drug development from target discovery through FDA approval. Their services include biomarker selection and assay development, pharmacodynamics testing, toxicity analysis, and various in vitro and ex vivo assays. By providing biomarker analysis and expertise, Biovays aims to streamline drug development, reduce costs, and improve success rates.
GVK Biosciences (GVK BIO) offers screening services for drug discovery to determine biological activity and properties customized to meet the research needs of the Pharma and Biotech industries. Our range of assays include Biochemical, Cellular, ADME assays & Animal models for profiling of NCEs for Potency, Selectivity, Efficacy, Drugability and Toxicity.
The document provides information about a bioinformatics lesson and exam. It states that there will be no lesson on December 4th. It then discusses the structure of the bioinformatics exam, which will randomly select images from a set of 713 images to display on a web page using JavaScript. The remainder of the document discusses various topics in comparative genomics, drug discovery, and other areas of bioinformatics.
Metin Bilgin is an experienced molecular and cellular biologist with over 12 years of postgraduate research experience. He co-developed the first proteome chip and assay protocols for protein array technology. His research has focused on studying cell cycle regulation, cytochrome P450 metabolism, and nuclear hormone receptor regulated drug metabolism through interactive proteomics, protein expression, and recombinant protein purification techniques. He holds a Ph.D. in Molecular and Cellular Biology from Szeged University and has worked in academic research positions in Turkey, Hungary, the UK, and the US.
Metin Bilgin is an experienced molecular and cellular biologist with over 12 years of postgraduate research experience. He co-developed the first proteome chip and assays for protein array technology. His research has focused on studying cell cycle regulation, cytochrome P450 metabolism, and nuclear hormone receptor-regulated drug metabolism. He is skilled in interactive proteomics, protein expression, purification of multi-protein complexes, and developing high-throughput molecular assays. Currently he works as a postdoctoral research associate at the University of Illinois studying regulation of cytochrome P450 activity by nuclear hormone receptor CAR.
This document provides an overview of the course Pharm 202 on Computer Aided Drug Design. It discusses the principles of drug discovery including modern target identification, lead identification, and data-driven approaches. The drug discovery process is outlined involving natural products, synthetic chemicals, and biologicals as starting points. Computer aided drug design has evolved from early visualization to modern automation and high-throughput approaches leveraging genomics, structural bioinformatics, and databases. The perspectives of targets, computers, and drugs in discovery are presented.
Metin Bilgin is a molecular and cellular biologist with over 12 years of postgraduate research experience. He has expertise in proteomics, protein expression, and characterization. Some of his accomplishments include co-developing the first proteome chip and establishing HTP assay protocols for protein array technology. He has studied various topics like cell cycle regulation, cytochrome P450 metabolism, and nuclear hormone receptor regulated drug metabolism. Currently, he is a postdoctoral research associate studying regulation of cytochrome P450 activity by nuclear hormone receptor CAR. He aims to work for a leading life sciences research company focused on discovery and translational medicine.
Presentation given as part of the EMBO Workshop on Plant-Microbe Interactions, at The Sainsbury Laboratory, Norwich, 20th June 2012. This presentation describes bioinformatic and statistical considerations for the prediction of plant pathogen effectors from genome sequences and annotation, with several literature examples.
This document discusses the evolution of systems biology and its various approaches over time, such as genomic and proteomic profiling, molecular interaction networks, disease models, and drug trials. It notes the movement from studying individual components to constructing network models of entire biological systems and pathways. It also addresses challenges like overgeneralizing findings and the need for more collaborative and open research.
Dr. M. N. Astagimath's presentation discusses genomics, proteomics, and metabolomics. The objectives are to understand the concepts and define each term. Genomics is the study of genomes and involves functional, structural, and epigenomics. Proteomics is the large-scale study of proteins and involves expression, interaction, and biomarker analysis. Metabolomics is the study of small molecule metabolites and their profiles can provide unique fingerprints of cellular processes. A variety of methods are used in each field like sequencing and mass spectrometry. The data has applications in medicine such as diagnosis, risk assessment, and bioengineering.
Similar to Target selection lead discovery medicinal drug discovery process design 5 powerpoint ppt templates. (19)
Business powerpoint presentations process diagram six decisions cycle flow ch...SlideTeam.net
The document describes how to edit and customize a business process diagram template in PowerPoint. It includes 6 steps represented by diverging arrows. At each step, text or images can be added and modified. All images are fully editable in terms of color, size, orientation, and other properties using the formatting and drawing tools in PowerPoint. This allows the template to be customized while maintaining a consistent visual structure.
Powerpoint presentations process management solution cycle flow network templ...SlideTeam.net
The document describes a 7 step converging arrows business process management solution. It includes 7 steps represented by arrows that converge on a central text box. All images are 100% editable in PowerPoint and allow the user to change color, size, orientation or any icon to their liking. The document also provides instructions on how to ungroup objects and edit their color using theme colors or by selecting fill and solid options.
Group of nine coverging arrows circular layout process power point slidesSlideTeam.net
The document describes how to edit a group of nine converging arrows diagram in PowerPoint. It includes instructions on ungrouping the object, editing the color, and editing the color by theme colors. The diagram can be customized by changing the color, size, and orientation of any icon. All images are fully editable in PowerPoint.
Four leading reason for cause cycle process diagram power point slidesSlideTeam.net
The document discusses editing images in PowerPoint. It provides instructions on how to ungroup objects, edit colors, and change colors using theme colors. The key steps are to right click objects to ungroup or access formatting options, select fill and color options to change the appearance, and choose from built-in theme colors.
To good world business powerpoint templates ideas processs andSlideTeam.net
The document contains instructions for editing business diagram images in PowerPoint. It explains how to ungroup objects, edit colors, and change colors using built-in theme colors. The purpose is to allow users to customize diagram images for business presentations.
Three converging arrows managing process layout cycle network power point slidesSlideTeam.net
The document describes how to edit icons in a PowerPoint presentation. It provides instructions on ungrouping objects, changing colors, and using theme colors. The steps include right clicking objects, choosing format options, and selecting fill and color options. The overall purpose is to demonstrate how to customize icons and make images fully editable.
Six coverging arrows for process to carried out charts and power point slidesSlideTeam.net
The document describes how to edit a diagram template with six converging arrows. Key points:
- The template can be used to bring presentations to life and capture audiences' attention.
- All images are 100% editable in PowerPoint, allowing the user to change color, size, and orientation of any icon.
- To ungroup objects, right click, select "Ungroup", and drag the selection arrow over parts to edit individually.
- To change an object's color, right click it, select "Format Shape", and choose a "Fill" color or gradient from the options provided. Colors can also be changed using the built-in theme colors.
Powerpoint presentations process management solution cycle flow network templ...SlideTeam.net
The document describes a 7 step converging arrows business process management solution. It includes 7 steps represented by arrows that converge on a central text box. All images are 100% editable in PowerPoint and allow the user to change color, size, orientation or any icon to their liking. The document also provides instructions on how to ungroup objects and edit their color using theme colors or by selecting fill and solid options.
Diverging arrows pointing specific directions processs and power point templatesSlideTeam.net
The document shows a diagram with diverging arrows pointing in different directions. The arrows can be edited in PowerPoint by ungrouping the object, changing the color using the format shape option or theme colors, and dragging the arrow to change its orientation. The diagram brings presentations to life and captures audiences' attention. It is fully editable and customizable in PowerPoint.
Templates process diagram with diverging arrows circular layout power point s...SlideTeam.net
The document is an illustration of a business process diagram with diverging arrows. It shows a process splitting into multiple parallel processes represented by arrows branching in different directions. All images in the diagram are fully editable in PowerPoint and can be modified by changing properties like color, size, and orientation. The document provides instructions on how to perform actions like ungrouping objects and editing colors using options in the PowerPoint interface.
Steps layout with converging arrows pointing to center cycle process power po...SlideTeam.net
The document describes how to edit icons in a PowerPoint presentation. It provides instructions for ungrouping objects, editing colors, and changing colors using built-in theme colors. The steps allow presenters to customize icons by changing their size, orientation, and colors to suit their liking.
Seven factors arrow pointing business process charts and power point slidesSlideTeam.net
The document appears to be a template for a diagram or presentation with 7 factors pointing to a central business process. The template includes placeholder text and images that can be customized. It is meant to bring presentations to life and capture audience attention. All elements are editable in PowerPoint.
Diverging arrows pointing different directions circular motion network power ...SlideTeam.net
The document shows a diagram template with diverging arrows pointing in different directions. The template can be customized with text in 8 boxes to bring presentations to life and capture audience attention. The images are fully editable in PowerPoint.
Diverging arrow process project activity diagram cycle power point slidesSlideTeam.net
The document describes a diverging arrow process project activity diagram. It includes steps numbered 1 through 5 with arrows connecting each step. Text placeholders throughout suggest editing the text to describe your own process. The document encourages downloading the diagram and editing it in PowerPoint to bring your own presentation to life and capture your audience's attention. It specifies that all images are 100% editable in terms of color, size, orientation, and text.
Diverging arrow pointing strategic planning process arrows network software p...SlideTeam.net
The document describes a diverging arrow diagram for strategic planning. It includes 11 points labeled 1 through 11 with arrows pointing in different directions. Below the diagram are bullet points describing how the diagram can be used to bring presentations to life, capture audiences' attention, and is fully editable in PowerPoint by changing colors, sizes, orientations of icons, ungrouping objects, and editing colors using theme colors. The document provides instructions for customizing a diverging arrow diagram template for strategic planning presentations.
Diverging arrows graphical view of different aspects cycle flow chart power p...SlideTeam.net
The document describes how to edit and customize diverging arrow diagrams created in PowerPoint. It includes 6 arrows branching from a central point and labeled text boxes that can be edited. The summary provides instructions on how to:
1. Ungroup individual elements to edit them separately.
2. Change colors by right clicking, selecting format shape, and choosing a solid or gradient fill color.
3. Change colors using built-in theme colors under the Design tab.
Diverging arrow pointing strategic planning process arrows network software p...SlideTeam.net
The document describes a diverging arrow diagram for strategic planning. It includes placeholders for text and logos. The diagram has 11 points connected by arrows and can be edited in PowerPoint. It is meant to help presentations and capture audience attention.
Business powerpoint presentations process diagram six decisions cycle flow ch...SlideTeam.net
The document shows a diverging arrows business process diagram with 6 decision points. The diagram can be edited in PowerPoint by changing the text, ungrouping objects to edit individual parts, and changing colors. All images are fully editable and the diagram is meant to capture audience attention and bring presentations to life.
Business powerpoint templates download process diagram cycleSlideTeam.net
The document is a 9 step converging arrows business process diagram template that allows users to customize each step with text and download the finished diagram. It provides an editable template to create a process flow chart for presentations.
Arrow diagram shows required order of tasks arrows software power point templ...SlideTeam.net
The document describes how to edit an arrow diagram in PowerPoint. It outlines the following steps:
1. Ungroup the object by right clicking, selecting group, and then ungroup to edit individual elements.
2. Edit the color of shapes by right clicking, selecting format shape, and choosing a solid or gradient fill color from the options.
3. Alternatively, colors can be changed by selecting a shape and choosing from the built-in theme colors in the design tab.
Satta matka fixx jodi panna all market dpboss matka guessing fixx panna jodi kalyan and all market game liss cover now 420 matka office mumbai maharashtra india fixx jodi panna
Call me 9040963354
WhatsApp 9040963354
SATTA MATKA DPBOSS KALYAN MATKA RESULTS KALYAN CHART KALYAN MATKA MATKA RESULT KALYAN MATKA TIPS SATTA MATKA MATKA COM MATKA PANA JODI TODAY BATTA SATKA MATKA PATTI JODI NUMBER MATKA RESULTS MATKA CHART MATKA JODI SATTA COM INDIA SATTA MATKA MATKA TIPS MATKA WAPKA ALL MATKA RESULT LIVE ONLINE MATKA RESULT KALYAN MATKA RESULT DPBOSS MATKA 143 MAIN MATKA KALYAN MATKA RESULTS KALYAN CHART
SATTA MATKA DPBOSS KALYAN MATKA RESULTS KALYAN CHART KALYAN MATKA MATKA RESULT KALYAN MATKA TIPS SATTA MATKA MATKA COM MATKA PANA JODI TODAY BATTA SATKA MATKA PATTI JODI NUMBER MATKA RESULTS MATKA CHART MATKA JODI SATTA COM INDIA SATTA MATKA MATKA TIPS MATKA WAPKA ALL MATKA RESULT LIVE ONLINE MATKA RESULT KALYAN MATKA RESULT DPBOSS MATKA 143 MAIN MATKA KALYAN MATKA RESULTS KALYAN CHART INDIA MATKA KALYAN SATTA MATKA 420 INDIAN MATKA SATTA KING MATKA FIX JODI FIX FIX FIX SATTA NAMBAR MATKA INDIA SATTA BATTA
The report *State of D2C in India: A Logistics Update* talks about the evolving dynamics of the d2C landscape with a particular focus on how brands navigate the complexities of logistics. Third Party Logistics enablers emerge indispensable partners in facilitating the growth journey of D2C brands, offering cost-effective solutions tailored to their specific needs. As D2C brands continue to expand, they encounter heightened operational complexities with logistics standing out as a significant challenge. Logistics not only represents a substantial cost component for the brands but also directly influences the customer experience. Establishing efficient logistics operations while keeping costs low is therefore a crucial objective for brands. The report highlights how 3PLs are meeting the rising demands of D2C brands, supporting their expansion both online and offline, and paving the way for sustainable, scalable growth in this fast-paced market.
Discover the Beauty and Functionality of The Expert Remodeling Serviceobriengroupinc04
Unlock your kitchen's true potential with expert remodeling services from O'Brien Group Inc. Transform your space into a functional, modern, and luxurious haven with their experienced professionals. From layout reconfiguration to high-end upgrades, they deliver stunning results tailored to your style and needs. Visit obriengroupinc.com to elevate your kitchen's beauty and functionality today.
Ellen Burstyn: From Detroit Dreamer to Hollywood Legend | CIO Women MagazineCIOWomenMagazine
In this article, we will dive into the extraordinary life of Ellen Burstyn, where the curtains rise on a story that's far more attractive than any script.
The Role of White Label Bookkeeping Services in Supporting the Growth and Sca...YourLegal Accounting
Effective financial management is important for expansion and scalability in the ever-changing US business environment. White Label Bookkeeping services is an innovative solution that is becoming more and more popular among businesses. These services provide a special method for managing financial duties effectively, freeing up companies to concentrate on their main operations and growth plans. We’ll look at how White Label Bookkeeping can help US firms expand and develop in this blog.
SATTA MATKA DPBOSS KALYAN MATKA RESULTS KALYAN CHART KALYAN MATKA MATKA RESULT KALYAN MATKA TIPS SATTA MATKA MATKA COM MATKA PANA JODI TODAY BATTA SATKA MATKA PATTI JODI NUMBER MATKA RESULTS MATKA CHART MATKA JODI SATTA COM INDIA SATTA MATKA MATKA TIPS MATKA WAPKA ALL MATKA RESULT LIVE ONLINE MATKA RESULT KALYAN MATKA RESULT DPBOSS MATKA 143 MAIN MATKA KALYAN MATKA RESULTS KALYAN CHART
Presentation by Herman Kienhuis (Curiosity VC) on Investing in AI for ABS Alu...Herman Kienhuis
Presentation by Herman Kienhuis (Curiosity VC) on developments in AI, the venture capital investment landscape and Curiosity VC's approach to investing, at the alumni event of Amsterdam Business School (University of Amsterdam) on June 13, 2024 in Amsterdam.
The Steadfast and Reliable Bull: Taurus Zodiac Signmy Pandit
Explore the steadfast and reliable nature of the Taurus Zodiac Sign. Discover the personality traits, key dates, and horoscope insights that define the determined and practical Taurus, and learn how their grounded nature makes them the anchor of the zodiac.
AI Transformation Playbook: Thinking AI-First for Your BusinessArijit Dutta
I dive into how businesses can stay competitive by integrating AI into their core processes. From identifying the right approach to building collaborative teams and recognizing common pitfalls, this guide has got you covered. AI transformation is a journey, and this playbook is here to help you navigate it successfully.
SATTA MATKA DPBOSS KALYAN MATKA RESULTS KALYAN CHART KALYAN MATKA MATKA RESULT KALYAN MATKA TIPS SATTA MATKA MATKA COM MATKA PANA JODI TODAY BATTA SATKA MATKA PATTI JODI NUMBER MATKA RESULTS MATKA CHART MATKA JODI SATTA COM INDIA SATTA MATKA MATKA TIPS MATKA WAPKA ALL MATKA RESULT LIVE ONLINE MATKA RESULT KALYAN MATKA RESULT DPBOSS MATKA 143 MAIN MATKA KALYAN MATKA RESULTS KALYAN CHART
Cover Story - China's Investment Leader - Dr. Alyce SUmsthrill
In World Expo 2010 Shanghai – the most visited Expo in the World History
https://www.britannica.com/event/Expo-Shanghai-2010
China’s official organizer of the Expo, CCPIT (China Council for the Promotion of International Trade https://en.ccpit.org/) has chosen Dr. Alyce Su as the Cover Person with Cover Story, in the Expo’s official magazine distributed throughout the Expo, showcasing China’s New Generation of Leaders to the World.
Tired of chasing down expiring contracts and drowning in paperwork? Mastering contract management can significantly enhance your business efficiency and productivity. This guide unveils expert secrets to streamline your contract management process. Learn how to save time, minimize risk, and achieve effortless contract management.
Target selection lead discovery medicinal drug discovery process design 5 powerpoint ppt templates.
1. Drug Discovery Process - Style 5
Cellular & Synthesis & Library Drug Affinity Animal Models Clinical Trials
Genetic Targets Isolation Development & Selectivity of Disease States & Therapeutics
Combinatorial Structure Activity Cellular Behavioural
Genomics Disease Models Studies
Chemistry Studies
Assay In Silico Mechanism Functional
Proteomics
Development Screening of Action Imaging
Bioinformatics High-throughput Chemical Lead Candidate Ex Vivo
Screening Synthesis Refinement Studies
Target Lead Medicinal In Vitro In Vivo
Selection Discovery Chemistry Studies Studies
www.slideteam.net Your logo
2. Drug Discovery Process - Style 5
Cellular & Synthesis & Library Drug Affinity Animal Models Clinical Trials
Genetic Targets Isolation Development & Selectivity of Disease States & Therapeutics
Combinatorial Structure Activity Cellular Behavioural
Genomics Disease Models Studies
Chemistry Studies
Assay In Silico Mechanism Functional
Proteomics
Development Screening of Action Imaging
Bioinformatics High-throughput Chemical Lead Candidate Ex Vivo
Screening Synthesis Refinement Studies
Target Lead Medicinal In Vitro In Vivo
Selection Discovery Chemistry Studies Studies
Text Here Text Here Text Here Text Here Text Here Text Here
• Your Text • Your Text • Your Text • Your Text • Your Text • Your Text
Goes here Goes here Goes here Goes here Goes here Goes here
• Download • Download • Download • Download • Download • Download
this this this this this this
awesome awesome awesome awesome awesome awesome
diagram diagram diagram diagram diagram diagram
www.slideteam.net Your logo
3. Drug Discovery Process - Style 5
Cellular & Synthesis & Library Drug Affinity Animal Models Clinical Trials
Genetic Targets Isolation Development & Selectivity of Disease States & Therapeutics
Combinatorial Structure Activity Cellular Behavioural
Genomics Disease Models Studies
Chemistry Studies
Assay In Silico Mechanism Functional
Proteomics
Development Screening of Action Imaging
Bioinformatics High-throughput Chemical Lead Candidate Ex Vivo
Screening Synthesis Refinement Studies
Target Lead Medicinal In Vitro In Vivo
Selection Discovery Chemistry Studies Studies
Text Here Text Here Text Here Text Here Text Here Text Here
• Your Text • Your Text • Your Text • Your Text • Your Text • Your Text
Goes here Goes here Goes here Goes here Goes here Goes here
• Download • Download • Download • Download • Download • Download
this this this this this this
awesome awesome awesome awesome awesome awesome
diagram diagram diagram diagram diagram diagram
www.slideteam.net Your logo
4. Drug Discovery Process - Style 5
Cellular & Synthesis & Library Drug Affinity Animal Models Clinical Trials
Genetic Targets Isolation Development & Selectivity of Disease States & Therapeutics
Combinatorial Structure Activity Cellular Behavioural
Genomics Disease Models Studies
Chemistry Studies
Assay In Silico Mechanism Functional
Proteomics
Development Screening of Action Imaging
Bioinformatics High-throughput Chemical Lead Candidate Ex Vivo
Screening Synthesis Refinement Studies
Target Lead Medicinal In Vitro In Vivo
Selection Discovery Chemistry Studies Studies
Text Here Text Here Text Here Text Here Text Here Text Here
• Your Text • Your Text • Your Text • Your Text • Your Text • Your Text
Goes here Goes here Goes here Goes here Goes here Goes here
• Download • Download • Download • Download • Download • Download
this this this this this this
awesome awesome awesome awesome awesome awesome
diagram diagram diagram diagram diagram diagram
www.slideteam.net Your logo
5. Drug Discovery Process - Style 5
Cellular & Synthesis & Library Drug Affinity Animal Models Clinical Trials
Genetic Targets Isolation Development & Selectivity of Disease States & Therapeutics
Combinatorial Structure Activity Cellular Behavioural
Genomics Disease Models Studies
Chemistry Studies
Assay In Silico Mechanism Functional
Proteomics
Development Screening of Action Imaging
Bioinformatics High-throughput Chemical Lead Candidate Ex Vivo
Screening Synthesis Refinement Studies
Target Lead Medicinal In Vitro In Vivo
Selection Discovery Chemistry Studies Studies
Text Here Text Here Text Here Text Here Text Here Text Here
• Your Text • Your Text • Your Text • Your Text • Your Text • Your Text
Goes here Goes here Goes here Goes here Goes here Goes here
• Download • Download • Download • Download • Download • Download
this this this this this this
awesome awesome awesome awesome awesome awesome
diagram diagram diagram diagram diagram diagram
www.slideteam.net Your logo
6. Drug Discovery Process - Style 5
Cellular & Synthesis & Library Drug Affinity Animal Models Clinical Trials
Genetic Targets Isolation Development & Selectivity of Disease States & Therapeutics
Combinatorial Structure Activity Cellular Behavioural
Genomics Disease Models Studies
Chemistry Studies
Assay In Silico Mechanism Functional
Proteomics
Development Screening of Action Imaging
Bioinformatics High-throughput Chemical Lead Candidate Ex Vivo
Screening Synthesis Refinement Studies
Target Lead Medicinal In Vitro In Vivo
Selection Discovery Chemistry Studies Studies
Text Here Text Here Text Here Text Here Text Here Text Here
• Your Text • Your Text • Your Text • Your Text • Your Text • Your Text
Goes here Goes here Goes here Goes here Goes here Goes here
• Download • Download • Download • Download • Download • Download
this this this this this this
awesome awesome awesome awesome awesome awesome
diagram diagram diagram diagram diagram diagram
www.slideteam.net Your logo
7. Drug Discovery Process - Style 5
Cellular & Synthesis & Library Drug Affinity Animal Models Clinical Trials
Genetic Targets Isolation Development & Selectivity of Disease States & Therapeutics
Combinatorial Structure Activity Cellular Behavioural
Genomics Disease Models Studies
Chemistry Studies
Assay In Silico Mechanism Functional
Proteomics
Development Screening of Action Imaging
Bioinformatics High-throughput Chemical Lead Candidate Ex Vivo
Screening Synthesis Refinement Studies
Target Lead Medicinal In Vitro In Vivo
Selection Discovery Chemistry Studies Studies
Text Here Text Here Text Here Text Here Text Here Text Here
• Your Text • Your Text • Your Text • Your Text • Your Text • Your Text
Goes here Goes here Goes here Goes here Goes here Goes here
• Download • Download • Download • Download • Download • Download
this this this this this this
awesome awesome awesome awesome awesome awesome
diagram diagram diagram diagram diagram diagram
www.slideteam.net Your logo
8. Drug Discovery Process - Style 5
Cellular & Synthesis & Library Drug Affinity Animal Models Clinical Trials
Genetic Targets Isolation Development & Selectivity of Disease States & Therapeutics
Combinatorial Structure Activity Cellular Behavioural
Genomics Disease Models Studies
Chemistry Studies
Assay In Silico Mechanism Functional
Proteomics
Development Screening of Action Imaging
Bioinformatics High-throughput Chemical Lead Candidate Ex Vivo
Screening Synthesis Refinement Studies
Target Lead Medicinal In Vitro In Vivo
Selection Discovery Chemistry Studies Studies
Text Here Text Here Text Here Text Here Text Here Text Here
• Your Text • Your Text • Your Text • Your Text • Your Text • Your Text
Goes here Goes here Goes here Goes here Goes here Goes here
• Download • Download • Download • Download • Download • Download
this this this this this this
awesome awesome awesome awesome awesome awesome
diagram diagram diagram diagram diagram diagram
www.slideteam.net Your logo
9. All images are 100% editable in Powerpoint
“Change color, size and orientation of any icon to your liking”
www.slideteam.net
10. Ungrouping the object
2
1
3
1. Right click the object.
2. Choose Group and then Ungroup.
3. Click beside the object and drag the arrow over it.
www.slideteam.net
11. Edit Color
2 3
1
1. Select the shape to change the color and Right click the object( click any object which you
want to change color)
2. Choose Format Shape in the dialog box.
3. Choose “Fill” in the Format Shape box then “Solid” or “Gradient” depending on the
appearance of the object. Change colour as shown in the picture.
www.slideteam.net